CVRdatabase
Menu

VenomAid Diagnostics ApS

Private limited companyCVR 39981165Kongens LyngbyActive

VenomAid Diagnostics ApS is a private limited company, based in Kongens Lyngby, active in research and experimental development on natural sciences and engineering, founded in 2018. Equity was negative at the end of 2025 (−DKK 11.3m). The company made a loss in both 2024 and 2025, most recently DKK 3.9m. 6 people are registered in the company's management and ownership.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 867k−43.8% vs. 2024
Net profit−DKK 3.9m−4.3% vs. 2024
Equity−DKK 11.3m−51.8% vs. 2024
Employees4latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss grew: from DKK 3.7m to DKK 3.9m (2024 → 2025).

Management and owners, last 24 months

  • New owners registered: Laustsen Ventures ApS (29/09/2025), Moleculo Holdings ApS (29/09/2025) and Sirius Ventures ApS (29/09/2025).
  • No longer registered as owner: Laustsen Ventures ApS (28/09/2025), Moleculo Holdings ApS (28/09/2025) and Sirius Ventures ApS (28/09/2025) (+2).

Registrations, last 24 months

  • 11/06/2025: Moved to Søltofts Plads 224, 1, 2800 Kongens Lyngby
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 12m−DKK 10m−DKK 8m−DKK 6m−DKK 4m−DKK 2mDKK 0202020212022202320242025
EquityNet profit
Financial figures for VenomAid Diagnostics ApS
202020212022202320242025Change
Revenue5590not statednot statednot statednot stated–
Gross profit258304154−603−867−43.8%
Operating profit (EBIT)25−24−958−2,753−3,223−3,167+1.7%
Profit before tax25−24−1,196−3,536−4,437−4,574−3.1%
Net profit20−24−915−2,921−3,694−3,854−4.3%
Total assets135956,70010,3327,5785,131−32.3%
Equity11894−821−3,742−7,436−11,290−51.8%
Liabilities1717,52014,07415,01416,421+9.4%
Cash and cash equivalents133776,0529,2836,4924,124−36.5%
Average number of employees––35550%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 1m−DKK 800k−DKK 600k−DKK 400k−DKK 200kDKK 0DKK 200kDKK 400kDKK 600kDKK 800k202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Negative equity

    Equity was −DKK 11.3m at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

  • Loss for 5 years in a row

    Net result has been negative in 2021–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for VenomAid Diagnostics ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202525/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202419/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202319/06/2024The companyPDFXBRL
202201/01/2022 – 31/12/202220/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202105/07/2022The companyPDF not statedXBRL
202001/01/2020 – 31/12/202016/05/2021The companyPDF not statedXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
01234508/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 867kNo. 323 of 421
Better than 23% of the companies in the industry
Equity−DKK 11.3mNo. 406 of 431
Better than 6% of the companies in the industry
Number of employees4No. 203 of 431
Better than 53% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 68,662of 69,742
Better than 2%
No. 69,624of 69,964
Better than 0%
Same industry and fewer than 20 employees329 companies in the comparison
No. 245of 323
Better than 24%
No. 314of 329
Better than 5%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 33,106of 33,588
Better than 1%
No. 33,388of 33,687
Better than 1%
All companies of type ApS66,508 companies in the comparison
No. 65,543of 66,379
Better than 1%
No. 66,168of 66,505
Better than 1%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. VenomAid Diagnostics ApS−DKK 867k
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. VenomAid Diagnostics ApS−DKK 3.9m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. VenomAid Diagnostics ApS−DKK 11.3m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. VenomAid Diagnostics ApS4
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Ubia Holdings ApS5%
  • Laustsen Ventures ApS20%
  • Moleculo Holdings ApS33.33%
  • Sirius Ventures ApS10%
VenomAid Diagnostics ApS

Management

5 active registrations

Executive management

Executive management at VenomAid Diagnostics ApS
NameRoleAppointed
Jonas Arnold Jürgensen-BreumDirector15/11/2020

Board of directors

Board of directors at VenomAid Diagnostics ApS
NameRoleAppointed
Mads Aage LaustsenBoard member30/08/2022
Andreas Hougaard Laustsen-KielBoard member30/08/2022
Gert Fisker TomczykChair of the board30/08/2022
Morten Boje MunkBoard member30/08/2022
Founders
Laustsen Ventures ApS, Moleculo Holdings ApS, Ubia Holdings ApS, Sirius Ventures ApS, RF Ventures ApS, Ortus Holdings ApS
Former management (1)
Former management at VenomAid Diagnostics ApS
NameRoleAppointedResigned
Rasmus Aasbjerg FriisDirector29/10/201815/11/2020

Signing rule: Selskabet tegnes af en direktør og bestyrelsesformanden, af to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.

Address and production units

1 active production units

Søltofts Plads 224
2800 Kongens Lyngby

Lyngby-Taarbæk Municipality · Postcode 2800

Production units
Production unitAddressEmployeesP number
VenomAid Diagnostics ApSSøltofts Plads 224, 1, 2800 Kongens Lyngby41024082381

Purpose

Selskabets formål er at udøve virksomhed med udvikling og salg af diagnostiske produkter til forgiftning forårsaget af dyr samt aktiviteter, som efter ledelsens skøn har tilknytning hertil.

The purpose is quoted from the register in Danish.

Changes year by year

34 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
202511 changesownership 8 · accounts 1 · address 1 · industry 1
  • LAUSTSEN VENTURES ApS registered as owner (20%)
  • Moleculo Holdings ApS registered as owner (33.33%)
  • Sirius Ventures ApS registered as owner (10%)
  • RF Ventures ApS is no longer registered as owner
  • Ortus Holdings ApS is no longer registered as owner
  • LAUSTSEN VENTURES ApS is no longer registered as owner
  • Moleculo Holdings ApS is no longer registered as owner
  • Sirius Ventures ApS is no longer registered as owner
  • Annual report for 2024 published
  • Moved to Søltofts Plads 224, 1, 2800 Kongens Lyngby
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20241 changeaccounts 1
  • Annual report for 2023 published
20232 changesaccounts 1 · address 1
  • Annual report for 2022 published
  • Moved to Kolonnevej 239, st, 2800 Kongens Lyngby
20226 changesmanagement 4 · accounts 1 · address 1
  • Mads Aage Laustsen appointed board member
  • Andreas Hougaard Laustsen-Kiel appointed board member
  • Gert Fisker Tomczyk appointed chair of the board
  • Morten Boje Munk appointed board member
  • Annual report for 2021 published
  • Moved to Elektrovej 331, 2800 Kongens Lyngby
20213 changesaddress 2 · accounts 1
  • Moved to Elektrovej 331, 2800 Kongens Lyngby
  • Moved to Elektrovej 331, 2800 Kongens Lyngby
  • Annual report for 2020 published
20202 changesmanagement 2
  • Jonas Arnold Jürgensen-Breum appointed director
  • Rasmus Aasbjerg Friis stepped down as director
20188 changesfounded 1 · management 1 · ownership 6
  • Registered as VenomAid Diagnostics ApS
  • Rasmus Aasbjerg Friis appointed director
  • RF Ventures ApS registered as owner (5%)
  • LAUSTSEN VENTURES ApS registered as owner (15%)
  • Ubia Holdings ApS registered as owner (5%)
  • Ortus Holdings ApS registered as owner (5%)
  • Moleculo Holdings ApS registered as owner (25%)
  • Sirius Ventures ApS registered as owner (25%)

Related companies

Same industry in Lyngby-Taarbæk

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction